Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

RHK.DE

Strong Buy

RHÖN-KLINIKUM Aktiengesellschaft · Healthcare · Germany · $1.1B · Avg Vol: $124K/d

89
StockRank
Get insider-trade alerts
Q
54
V
63
M
71
P/E (TTM)
22.8x
ROE
3.3%
D/E
0.1x
Dividend %
1.4%
Dir. Trades · 180d
None →
Buybacks · 180d
None →
Loading 1Y...
PRICE (1Y)+10.5%
14.6015.3015.9916.6917.38Jul 16Aug 6Aug 27
SMA 50SMA 200

Close
$17.03
RSI (14)
38.5
52W High
$18.19
From 52W High
0.9%

SCORE BREAKDOWN

Quality
54
ROIC
3.9%55.1
ROE
3.3%53.2
GP/Assets
12.0%30.6
Op. Margin
2.3%48.6
FCF/Assets
-2.3%40.5
Piotroski
497.9
Int. Cover
19.7x71.5
D/E Ratio
0.09x63.9
Current Ratio
2.63x49.2
Value
63
P/E (TTM)
22.8x53.1
EV/EBITDA
7.3x82.6
P/FCF
—N/A
P/B
0.7x91.6
P/S
0.5x92.7
Div Yield
1.4%34.2
Momentum
71
52W High %
94%89.4
RS 6M
11%73.4
SMA 50/200
1.07x72.8
EPS Rev 4W
—N/A
EPS Rev 12W
—N/A
EPS Improve
+23%37.6
Q Growth
29%64.3

FUNDAMENTALS

Market Cap
$1.1B
P/E (Forward)
18.5x
Gross Margin
10.7%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of RHK.DE are excluded.

TickerCompanyMkt CapStockRankSignal
RHK.DERHÖN-KLINIKUM Aktiengesellschaft(you)$1.1B89Strong Buy
LIK.DELIMES Schlosskliniken AG$200M89Strong Buy
MED.DEMEDICLIN Aktiengesellschaft$305M99Strong Buy
FME.DEFresenius Medical Care AG$12.5B94Strong Buy
FRE.DEFresenius SE & Co. KGaA$25.5B82Strong Buy
EUZ.DEEckert & Ziegler SE$962M79Buy
DMP.DEDermapharm Holding SE$2.3B94Strong Buy
DRW8.DEDrägerwerk AG & Co. KGaA$1.8B100Strong Buy
SBS.DEStratec SE$317M83Strong Buy
M12.DEM1 Kliniken AG$399M99Strong Buy

Peer medians: ROE 7.2% · P/E 16.5x · Gross margin 45.7%

RHÖN-KLINIKUM Aktiengesellschaft (RHK.DE): Stock Score Summary

RHÖN-KLINIKUM Aktiengesellschaft (RHK.DE) has a MoatMap StockRank of 89/100 based on Quality (54/100), Value (63/100), and Momentum (71/100) factor scores. The current signal is STRONG BUY.

Key Financial Metrics

Price$17.03
Market Cap$1.1B
P/E (TTM)22.81
P/E (Forward)18.48
Price/Book0.74
Return on Equity3.3%
Return on Invested Capital3.9%
Debt/Equity0.09x
Gross Margin10.7%
Operating Margin2.3%
Revenue Growth5.0%
Dividend Yield1.4%
Free Cash Flow$-49M

RHÖN-KLINIKUM Aktiengesellschaft operates in the Medical Care Facilities industry, part of the Healthcare sector (Germany).

Frequently Asked Questions

What is RHÖN-KLINIKUM Aktiengesellschaft’s (RHK.DE) StockRank?
MoatMap’s StockRank for RHÖN-KLINIKUM Aktiengesellschaft (RHK.DE) is 89/100, with a Strong Buy signal. It is a composite of Quality (54), Value (63), and Momentum (71) factor ranks across MoatMap’s 20,000+ stock universe.
Does RHÖN-KLINIKUM Aktiengesellschaft have an economic moat?
RHÖN-KLINIKUM Aktiengesellschaft (RHK.DE) has a Quality factor score of 54/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage: the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is RHÖN-KLINIKUM Aktiengesellschaft a buy, hold, or sell?
MoatMap’s current signal for RHÖN-KLINIKUM Aktiengesellschaft (RHK.DE) is Strong Buy, based on a StockRank of 89/100. Signals are derived mechanically from the StockRank composite and should be one input among many; combine with your own thesis on management, competitive position, and valuation.
What sector is RHÖN-KLINIKUM Aktiengesellschaft in?
RHÖN-KLINIKUM Aktiengesellschaft (RHK.DE) operates in the Healthcare sector, specifically the Medical Care Facilities industry (Germany).
Browse all ranked stocksRHK.DE deep dive reportAI ChampionsHow we score stocksSense-check another stock